Ventyx Biosciences Inc (NASDAQ:VTYX) price closed lower on Tuesday, March 26, dropping -10.40% below its previous close.
A look at the daily price movement shows that the last close reads $6.54. The company’s 5Y monthly beta was ticking 0.36. Taking into account the 52-week price action we note that the stock hit a 52-week high of $40.58 and 52-week low of $1.87.
Ventyx Biosciences Inc, which has a market valuation of $347.15 million, is expected to release its quarterly earnings report Feb 27, 2024. Analysts tracking VTYX have forecast the quarterly EPS to shrink by -0.69 per share this quarter, while the same analysts predict the annual EPS to hit -$2.67 for the year 2024 and up to -$2.59 for 2025. In this case, analysts estimate an annual EPS growth of 19.10% for the year and 3.00% for the next year.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give VTYX a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that VTYX’s price is at present -26.86% off the SMA20 and 21.17% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 42.70, with weekly volatility standing at 9.74%. The indicator jumps to 14.82% when calculated based on the past 30 days. Ventyx Biosciences Inc (NASDAQ:VTYX)’s beta value is holding at 0.33, while the average true range (ATR) indicator is currently reading 0.89.
An analysis of the Ventyx Biosciences Inc (NASDAQ:VTYX) stock in terms of its daily trading volume indicates that the 3-month average is 4.47 million. However, this figure increases on the past 10-day timeline to an average of 1.43 million.
Current records show that the company has 59.24M in outstanding shares. The insiders’ percentage holdings are 20.51% of outstanding shares while the percentage share held by institutions stands at 83.21%. The stats also highlight that short interest as of Feb 29, 2024, stood at 9.19 million shares, which puts the short ratio at the time at 1.21. From this we can glean that short interest is 15.52% of company’s current outstanding shares. Notably, we see that shares short in February rose slightly given the previous month’s figure stood at 4.86 million. But the 137.25% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
